Investors continue to monitor emerging growth companies across Artificial Intelligence (AI), Defense Technology, Biotechnology, Blockchain, Telecommunications, Digital Infrastructure, and Entertainment, as several small-cap stocks report significant operational and corporate developments.
Atai Beckley (NASDAQ: ATAI) continues advancing its pipeline of next-generation mental health therapies, led by BPL-003, which has received FDA Breakthrough Therapy Designation and entered Phase 3 clinical development for treatment-resistant depression. The company is also progressing additional clinical-stage programs targeting major depressive disorder, generalized anxiety disorder, social anxiety disorder, and opioid use disorder.
Peraso Inc. (NASDAQ: PRSO) continues expanding its 60GHz millimeter-wave (mmWave) communications platform designed for military drones, AI infrastructure, autonomous systems, robotics, drone swarms, and tactical communications. Recent advancements include adaptive beamforming, anti-jamming technology, low-probability-of-intercept communications, GPS-denied networking, and secure high-capacity wireless connectivity, positioning the company within several rapidly growing defense and AI markets.
IQSTEL Inc. (NASDAQ: IQST) reported preliminary first-half 2026 revenue of approximately $207 million, representing 59% year-over-year growth from $130 million in the prior-year period. The company continues expanding across telecommunications, fintech, AI-powered communications, cybersecurity, and digital infrastructure, reinforcing its position as a diversified global technology provider.
The GrowHub Ltd. (NASDAQ: TGHL) continues building its blockchain-enabled technology platform focused on product traceability, supply chain transparency, anti-counterfeiting, and carbon management. Its solutions serve customers seeking greater authentication, sustainability, and digital supply chain visibility across global markets.
Kartoon Studios (NYSE: TOON) continues strengthening its balance sheet after receiving an initial $39.2 million cash payment from litigation settlements totaling approximately $78.5 million. Combined with new licensing agreements involving Mattel's Masters of the Universe and American Girl, and with roughly 60% of its 2026 content slate still scheduled for release, the company enters what many investors view as a catalyst-rich growth period after shares retraced from a 52-week high of approximately $1.27 to near recent lows.
Liminatus Pharma, Inc. (NASDAQ: LIMN) also remains on investor watchlists as market participants monitor developments surrounding the company's oncology pipeline and biotechnology initiatives, reflecting continued interest in emerging healthcare innovators.
As investment continues flowing into AI, biotechnology, autonomous systems, defense technology, blockchain, digital infrastructure, and next-generation communications, companies including ATAI, PRSO, IQST, TGHL, TOON, and LIMN remain active names to watch as they pursue growth across some of today's fastest-evolving technology sectors.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com
